Cargando…

Glibenclamide Posttreatment Does Not Inhibit Levcromakalim Induced Headache in Healthy Participants: A Randomized Clinical Trial

Intravenous infusion of ATP-sensitive potassium channel (K(ATP)) opener levcromakalim causes headache in humans and implicates K(ATP) channels in headache pathophysiology. Whether K(ATP) channel blocker glibenclamide inhibits levcromakalim-induced headache has not yet been elucidated. We aimed to in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kokoti, Lili, Al-Karagholi, Mohammad Al-Mahdi, Waldorff Nielsen, Cherie Amalie, Ashina, Messoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121935/ https://www.ncbi.nlm.nih.gov/pubmed/36763326 http://dx.doi.org/10.1007/s13311-023-01350-y

Ejemplares similares

The Effect of K(ATP) Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers
por: Coskun, Hande, et al.
Publicado: (2021)

Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies
por: Thuraiaiyah, Janu, et al.
Publicado: (2022)

The role of high‐conductance calcium‐activated potassium channel in headache and migraine pathophysiology
por: Al‐Karagholi, Mohammad Al‐Mahdi, et al.
Publicado: (2022)

Reducing Episodic Cluster Headaches: Focus on Galcanezumab
por: Pellesi, Lanfranco, et al.
Publicado: (2020)

PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
por: Guo, Song, et al.
Publicado: (2022)

Debate: Are cluster headache and migraine distinct headache disorders?
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2022)

Correction: PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
por: Guo, Song, et al.
Publicado: (2023)

Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache
por: Ghanizada, Hashmat, et al.
Publicado: (2020)

Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial
por: Pellesi, Lanfranco, et al.
Publicado: (2021)

The K(ATP) channel in migraine pathophysiology: a novel therapeutic target for migraine
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2017)

Calcitonin Gene-Related Peptide in Tension-Type Headache
por: Ashina, Messoud
Publicado: (2001)

Chronic headache and nitric oxide inhibitors
por: Ashina, Messoud, et al.
Publicado: (2001)

Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
por: Al‐Karagholi, Mohammad Al‐Mahdi, et al.
Publicado: (2021)

Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study
por: Pellesi, Lanfranco, et al.
Publicado: (2022)

PACAP38 in human models of primary headaches
por: Ashina, Håkan, et al.
Publicado: (2017)

Investigation of cortical thickness and volume during spontaneous attacks of migraine without aura: a 3-Tesla MRI study
por: Amin, Faisal Mohammad, et al.
Publicado: (2021)

Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans
por: Do, Thien Phu, et al.
Publicado: (2023)

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
por: Ashina, Messoud, et al.
Publicado: (2018)

Acute and preventive pharmacological treatment of post-traumatic headache: a systematic review
por: Larsen, Eigil Lindekilde, et al.
Publicado: (2019)

A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine
por: Wu, Shouyi, et al.
Publicado: (2022)

Correction: Investigation of cortical thickness and volume during spontaneous attacks of migraine without aura: a 3-Tesla MRI study
por: Amin, Faisal Mohammad, et al.
Publicado: (2023)

Cluster headache – The worst possible pain on YouTube
por: Chaudhry, Basit Ali, et al.
Publicado: (2022)

Interrelations between migraine-like headache and persistent post-traumatic headache attributed to mild traumatic brain injury: a prospective diary study
por: Ashina, Håkan, et al.
Publicado: (2020)

Characterizing healthcare utilization patterns in a Danish population with headache: results from the nationwide headache in Denmark (HINDER) panel
por: Do, Thien Phu, et al.
Publicado: (2023)

Lipofundin MCT/LCT Inhibits Levcromakalim-Induced Vasodilation by Inhibiting Endothelial Nitric Oxide Release
por: Lee, Soo Hee, et al.
Publicado: (2020)

Levcromakalim provokes an acute rapid-onset migraine-like phenotype without inducing cortical spreading depolarization
por: Alpay, Berkay, et al.
Publicado: (2023)

Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
por: Ashina, Messoud, et al.
Publicado: (2021)

Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study
por: Ashina, Håkan, et al.
Publicado: (2020)

Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers
por: Hansen, Jakob Møller, et al.
Publicado: (2009)

Migraine and cluster headache – the common link
por: Vollesen, Anne Luise, et al.
Publicado: (2018)

The effect of sodium nitroprusside on cerebral haemodynamic and headache in healthy subjects
por: Guo, S, et al.
Publicado: (2013)

Headaches in the emergency department –a survey of patients’ characteristics, facts and needs
por: Doretti, Alberto, et al.
Publicado: (2019)

Involvement of Potassium Channel Signalling in Migraine Pathophysiology
por: Al-Karagholi, Mohammad Al-Mahdi
Publicado: (2023)

The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study
por: Rasmussen, Nadja Bredo, et al.
Publicado: (2023)

Barriers and gaps in headache education: a national cross-sectional survey of neurology residents in Denmark
por: Do, Thien Phu, et al.
Publicado: (2022)

One-quarter of individuals with weekly headache have never consulted a medical doctor: a Danish nationwide cross-sectional survey
por: Do, Thien Phu, et al.
Publicado: (2022)

The pharmacological effect of BGC20-1531, a novel prostanoid EP(4) receptor antagonist, in the Prostaglandin E(2) human model of headache
por: Antonova, Maria, et al.
Publicado: (2011)

Correction: The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study
por: Rasmussen, Nadja Bredo, et al.
Publicado: (2023)

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018)

Assessment of glibenclamide pharmacokinetics in poloxamer 407-induced hyperlipidemic rats
por: Bin Jardan, Yousef A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1gja3v6gj1bnhi2g5m8drjrsoa